| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.093 | 0.1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.1 |